BioSpace News Archive

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron.

Nuvo Group—a private company commercializing INVU by Nuvo™, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform—announced today that it has entered into a collaboration agreement with Unified Women’s Healthcare (“Unified”), the largest, diversified physician practice management company dedicated solely to women in the United States.

THREAD, a leading technology and service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired inVibe, the leading voice-powered research and insights technology solution for the life sciences and health care industry.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational oral formulation of edaravone (MT-1186) for the treatment of amyotrophic lateral sclerosis (ALS).

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that it was honored as a recipient of China’s Suzhou Industrial Park’s (SIP) 15th Science and Technology Leaders Innovation Award for the Company’s Accelerate Pheno® System.

Elpis Biopharmaceuticals, a clinical stage biopharmaceutical company developing next generation multifunctional immunotherapies to transform cancer treatment, today announced the appointment of Vincenzo Bronte, M.D., of the University of Verona in Italy, to its Scientific Advisory Board.

Waters Corporation will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time.

International medical imaging IT and cybersecurity company Sectra has signed a contract for radiology imaging with an NHS consortium in Surrey and Sussex in the UK.

CORCYM, the medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces the first Perceval implant in China, after the recent approval from the NMPA - National Medical Products Administration.

The nizatidine market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2031.